Login / Signup

Efficacy of Post-Operative Medication to Prevent Recurrence of Endometrioma: Cyclic Oral Contraceptive (OC) After Gonadotropin-Releasing Hormone (GnRH) Agonist Versus Dienogest.

Seung-Hye ChoiSung Eun KimHyun Hye LimDong-Yun LeeDoo Seok Choi
Published in: Journal of Korean medical science (2022)
Long-term use of OC after GnRH agonist as well as that of dienogest treatment are effective postoperative medical therapies for preventing endometrioma recurrence. Thus, the choice of regimen can be individualized or used interchangeably depending on patient condition, need for contraception, and compliance with drug therapy.
Keyphrases
  • healthcare
  • free survival
  • adverse drug
  • patients undergoing
  • case report
  • stem cells
  • emergency department
  • combination therapy
  • decision making